Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
Author:
Affiliation:
1. Department of Hematology and Oncology Ulsan University Hospital, University of Ulsan College of Medicine Ulsan South Korea
2. Department of Hematology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea
Funder
Asan Institute for Life Sciences, Asan Medical Center
Publisher
Wiley
Subject
Transplantation
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14199
Reference22 articles.
1. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
2. Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation
3. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
4. Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
5. Second HLA‐identical sibling transplants for leukemia recurrence;Mrsic M;Bone Marrow Transplant,1992
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in second hematopoietic stem cell transplantation;Frontiers in Immunology;2024-07-09
2. How risky is a second allogeneic stem cell transplantation?;Leukemia;2024-06-25
3. A comprehensive literature review on image captioning methods and metrics based on deep learning technique;Multimedia Tools and Applications;2024-02-20
4. Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population;Transplantation and Cellular Therapy;2023-08
5. A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT;Blood Advances;2023-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3